Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients

被引:0
|
作者
Carlos Pérez-Ruixo
José E. Peris
Vanesa Escudero-Ortiz
Pedro Bretcha-Boix
José Farré-Alegre
Juan José Pérez-Ruixo
Belén Valenzuela
机构
[1] University of Valencia,Pharmacy and Pharmaceutical Technology Department
[2] Hospital Quirón Torrevieja,Platform of Oncology
[3] AMGEN,Pharmacokinetics and Drug Metabolism
[4] UCAM Catholic University of San Antonio,Cathedra of Multidisciplinary Oncology
[5] Hospital Quiron Torrevieja,Personalized Pharmacotherapy Unit, Platform of Oncology
[6] Consulting Projects for Research,undefined
来源
关键词
Oxaliplatin bioavailability; Peritoneal carcinomatosis; Pharmacokinetics; NONMEM; Hyperthermic intraperitoneal chemotherapy; Cytoreductive surgery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1009 / 1020
页数:11
相关论文
共 50 条
  • [1] Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients
    Perez-Ruixo, Carlos
    Peris, Jose E.
    Escudero-Ortiz, Vanesa
    Bretcha-Boix, Pedro
    Farre-Alegre, Jose
    Jose Perez-Ruixo, Juan
    Valenzuela, Belen
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1009 - 1020
  • [2] Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery
    Carlos Pérez-Ruixo
    Belén Valenzuela
    José Esteban Peris
    Pedro Bretcha-Boix
    Vanesa Escudero-Ortiz
    José Farré-Alegre
    Juan José Pérez-Ruixo
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 693 - 704
  • [3] Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery
    Perez-Ruixo, Carlos
    Valenzuela, Belen
    Esteban Peris, Jose
    Bretcha-Boix, Pedro
    Escudero-Ortiz, Vanesa
    Farre-Alegre, Jose
    Jose Perez-Ruixo, Juan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 693 - 704
  • [4] Neutrophil Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin
    Perez-Ruixo, Carlos
    Valenzuela, Belen
    Esteban Peris, Jose
    Bretcha-Boix, Pedro
    Escudero-Ortiz, Vanesa
    Farre-Alegre, Jose
    Jose Perez-Ruixo, Juan
    CLINICAL PHARMACOKINETICS, 2013, 52 (12) : 1111 - 1125
  • [5] Neutrophil Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin
    Carlos Pérez-Ruixo
    Belén Valenzuela
    José Esteban Peris
    Pedro Bretcha-Boix
    Vanesa Escudero-Ortiz
    José Farré-Alegre
    Juan José Pérez-Ruixo
    Clinical Pharmacokinetics, 2013, 52 : 1111 - 1125
  • [6] Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin
    Perez-Ruixo, Carlos
    Valenzuela, Belen
    Esteban Peris, Jose
    Bretcha-Boix, Pedro
    Escudero-Ortiz, Vanesa
    Farre-Alegre, Jose
    Perez-Ruixo, Juan Jose
    AAPS JOURNAL, 2016, 18 (01): : 239 - 250
  • [7] Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin
    Carlos Pérez-Ruixo
    Belén Valenzuela
    José Esteban Peris
    Pedro Bretcha-Boix
    Vanesa Escudero-Ortiz
    José Farré-Alegre
    Juan José Pérez-Ruixo
    The AAPS Journal, 2016, 18 : 239 - 250
  • [8] Safety and Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with High-Dose Oxaliplatin in Patients with Peritoneal Carcinomatosis
    Wim P. Ceelen
    Marc Peeters
    Philippe Houtmeyers
    Christophe Breusegem
    Filip De Somer
    Piet Pattyn
    Annals of Surgical Oncology, 2008, 15 : 535 - 541
  • [9] Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis
    Ceelen, Wim P.
    Peeters, Marc
    Houtmeyers, Philippe
    Breusegem, Christophe
    De Somer, Filip
    Pattyn, Piet
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (02) : 535 - 541
  • [10] Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin as a Treatment for Peritoneal Carcinomatosis Arising from the Appendix
    Marcotte, E.
    Drolet, P.
    Dube, P.
    Mitchell, A.
    Leblanc, G.
    Leclerc, Y. E.
    Frenette, S.
    Sideris, L.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S103 - S103